Eam Global Investors LLC Intra Cellular Therapies, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$46.37 - $73.65 $2.34 Million - $3.71 Million
50,401 New
50,401 $3.61 Million
Q2 2022

Aug 12, 2022
SELL
$43.0 - $65.64 $518,365 - $791,290
-12,055 Reduced 24.2%
37,763 $2.16 Million
Q1 2022

May 13, 2022
BUY
$38.74 - $62.09 $1,937 - $3,104
50 Added 0.1%
49,818 $3.05 Million
Q4 2021

Feb 11, 2022
BUY
$35.2 - $53.42 $1.75 Million - $2.66 Million
49,768 New
49,768 $2.61 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email